David Einhorn
Greenlight Capital
David Einhorn Danimer Scientific Inc stake
total: 357
Greenlight Capital DNMR trades
- Total transactions:
- 13
- New positions:
- 1
- Sold out:
- 1
- Added:
- 7
- Reduced:
- 4
- Held since:
- 2020 Q4
- Held for:
- 16 quarters
- Latest activity:
- 2024 Q4
According to 2026 Q2 report, David Einhorn doesn't hold any Danimer Scientific Inc (DNMR) shares. To date, the estimated cost basis is nearly $11.45 for "buy" trades and estimated average "sell" price is $2.78. Greenlight Capital first purchased DNMR in 2020 Q4, initially acquiring about 2.30M shares. Since the initial investment in Danimer Scientific Inc (DNMR), Greenlight Capital has made 12 more transactions.
When did David Einhorn sell Danimer Scientific Inc (DNMR)?
David Einhorn sold off the entire Danimer Scientific Inc (DNMR) position in 2024 Q4.
When did David Einhorn buy Danimer Scientific Inc (DNMR)?
David Einhorn first invested in Danimer Scientific Inc (DNMR) in 2020 Q4 at the reported quarter-end price of $17.64 per share.
What's the cost basis of Greenlight Capital's DNMR stake?
The estimated cost basis for Danimer Scientific Inc (DNMR) stake is around $11.45 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $11.45
- Weighted AVG sell price:
- $2.78
David Einhorn's historical trades in Danimer Scientific Inc
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q4
|
0.00%
|
0
|
$0.45
|
|
-100% (-1,097,461)
|
-0.02%
|
|
2024 Q3
|
0.02%
|
1,097,461
|
$0.45
|
$498,466
|
-59.87% (-1,637,119)
|
-0.04%
|
|
2024 Q2
|
0.08%
|
2,734,580
|
$0.60
|
$1,649,498
|
-24.98% (-910,615.14)
|
-0.03%
|
|
2023 Q4
|
0.14%
|
3,645,195.14
|
$0.77
|
$2,789,272
|
+5.07% (+175,809.37)
|
+0.01%
|
|
2023 Q3
|
0.31%
|
3,469,385.77
|
$1.55
|
$5,387,568
|
+2.07% (+70,235.77)
|
+0.01%
|
|
2023 Q1
|
0.48%
|
3,399,150
|
$2.59
|
$8,797,500
|
+13.33% (+399,900)
|
+0.06%
|
|
2022 Q4
|
0.28%
|
2,999,250
|
$1.34
|
$4,027,500
|
+16.89% (+433,304.98)
|
+0.04%
|
|
2022 Q3
|
0.40%
|
2,565,945.02
|
$2.21
|
$5,678,000
|
+134.46% (+1,471,552.02)
|
+0.23%
|
|
2021 Q4
|
0.43%
|
1,094,393
|
$6.39
|
$6,995,000
|
-65.18% (-2,049,050.28)
|
-0.88%
|
|
2021 Q3
|
2.58%
|
3,143,443.28
|
$12.26
|
$38,532,000
|
+11.86% (+333,250)
|
+0.27%
|
|
2021 Q2
|
3.31%
|
$18.79
|
-2.06% (-59,141.21)
|
|||
|
2021 Q1
|
5.66%
|
$28.32
|
+24.75% (+569,242.99)
|
|||
|
2020 Q4
|
2.47%
|
$17.64
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.